Status:
COMPLETED
Physical Therapy in Women With Interstitial Cystitis
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsors:
University of Pennsylvania
Conditions:
Interstitial Cystitis
Painful Bladder Syndrome
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
There are many different treatments that doctors recommend for patients with IC/PBS. Only a few research studies have been done to evaluate treatments given to patients. Treatment choices can be of tw...
Detailed Description
The Urologic Pelvic Pain Syndromes (UPPS) are characterized by pelvic pain with concurrent urinary symptoms. Broadly, the UPPS comprise Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) in men a...
Eligibility Criteria
Inclusion
- Participant has signed and dated the appropriate Informed Consent document.
- Female participant is ≥ 18 years of age.
- Currently using an approved method of birth control, or surgically sterile, or of non-child bearing age with no menstrual period for the past year.
- Participant has a clinical diagnosis of IC/PBS in the opinion of the investigator.
- Participant with IC/PBS has reported a bladder pain/discomfort score of 3 or greater on a 0-10 Likert scale over the previous four weeks. This bladder pain/discomfort criterion must be met at each of the two baseline screening visits as reported by the participant.
- Participant with IC/PBS has reported a symptom score of abnormal urinary frequency of 3 or greater on a 0-10 Likert scale over the previous four weeks. This frequency criterion must be met at each of the two baseline screening visits, as reported by the participant.
- Participant has had symptoms of discomfort or pain in the pelvic region for at least a three (3) month period within the last six (6) months.
- Current symptoms have been present for less than 3 years. If similar symptoms were present in the past, they must have been completely resolved for at least one year prior to onset of current symptoms.
- Participant has previously undergone at least one course of therapy (other than physical therapy) for her symptoms.
- Presence of tenderness/pain to palpation found by the physician in one of the pelvic floor musculature domains during the first baseline screening visit physical examination which are confirmed by the physical therapist at screening visit 2. Presence of tenderness/pain is defined as a mild, moderate or severe finding by the physician at visit 1 and physical therapist at visit 2. The pelvic floor musculature domains are defined as: anterior or posterior levator muscles, obturator internus muscles and urogenital diaphragm (bulbospongiosus, superficial transverse perinei, ischiocavernosus, central tendon/perineal body). The assessment of tenderness/pain at Visits 1 and 2 do not need to be identical in severity or location in order for the participant to be eligible.
Exclusion
- Participant has relevant, painful scars on lower abdominal wall that, in the opinion of the study physician or physical therapist, is unlikely to respond to physical therapy without adjuvant therapy such as injection /needling.
- A positive urine culture (defined as \>100,000 CFU/ml) is exclusionary. A negative urine culture within 1 month of study enrollment is acceptable.
- Participant is unable to tolerate insertion of one or two vaginal examining fingers (e.g. vulvar allodynia), or one rectal examining finger.
- Participant had prior course of physical therapy that included manual therapy with connective tissue manipulation by physical therapist for same symptoms. Prior treatment by therapist with biofeedback, electrical stimulation, or pelvic floor exercises is not exclusionary.
- Participant has relevant neurologic disorder that affects bladder and/or neuromuscular function in the opinion of the investigator.
- Participant has active urethral or ureteral calculi, urethral diverticulum.
- Participant has a history of pelvic radiation therapy, tuberculous cystitis, bladder cancer, carcinoma in situ, or urethral cancer.
- Participant has/reports any severe debilitating or urgent concurrent medical condition.
- Participant has a potentially significant pelvic pathology or abnormalities on examination or prior imaging, including prolapse beyond the hymenal ring, pelvic mass, etc. that could cause or contribute to the clinical symptoms or require treatment.
- Participant is unlikely to be compliant due to unmanaged medical or psychological condition, including neurological, psychological or speech /language problems that will interfere with her ability to complete the study.
- Participant has an imminent change in residence or other social factors that could compromise compliance with the protocol.
- Pregnancy or refusal of medically approved/reliable birth control in women of child-bearing potential.
- Participant has pain, frequency, urgency symptoms present only during menses.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00733603
Start Date
June 1 2008
End Date
December 1 2009
Last Update
March 22 2021
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of California San Diego
San Diego, California, United States, 92093
2
Stanford University Medical center
Stanford, California, United States, 94305
3
Loyola University Medical Center
Maywood, Illinois, United States, 60153
4
University of Iowa Hospitals and Clinic
Iowa City, Iowa, United States, 52242